These findings were consistent with those of a previous report evaluating the effects of a combination of ramucirumab and paclitaxel in GC cell lines, in which E‐cadherin was upregulated and N‐cadherin was downregulated.40 The gene discussed is CDH1; the disease is gastric cancer.